Aptitude Health

05/30/2026

We're excited to be at ! Connect with our team at Booth #12119 to explore how Aptitude Health's real-world insights uncover the drivers behind clinical decision-making and strengthen oncology strategies.

Learn more about us: https://www.aptitudehealth.com/

05/28/2026

Oncology and hematology professionals: Make your expertise go further! Join the Axess Network, a proprietary global network of 6,500+ key opinion leaders and health care providers shaping clinical innovation through unbiased collaboration with peers, community oncologists, and life science companies.​

Be part of a network committed to improving outcomes and advancing cancer care through collaboration and real-world clinical insight.​

Learn more about the Axess Network: https://www.aptitudehealth.com/axess-network/

05/26/2026

New network meta-analysis compares first-line immunotherapy regimens for recurrent or metastatic cervical cancer. Read more:

A meta-analysis compares pembrolizumab, atezolizumab, and cadonilimab combinations for /metastatic cervical cancer

05/25/2026

In observance of Memorial Day, our US offices will be closed on Monday, May 25. As a global organization, we take this time to acknowledge the significance of the day while continuing to support our clients and partners around the world.

05/21/2026

Advances in hematology presented at require meaningful interpretation to drive impact. Aptitude Health delivers insight reports that capture the most important findings from across complex hematologic malignancies including lymphoma, leukemia, and multiple myeloma, informed by exclusive virtual roundtables with leading hematology experts. ​

✅ Real-world summaries of key presentations​
✅ In-depth analysis of emerging data​ ​​
✅ Actionable insights from expert-led evaluation​​
✅ Comprehensive reports to inform your oncology strategy​​

Reserve your EPICS Conference Coverage report today: https://www.aptitudehealth.com/oncology-reports/

05/20/2026

In today’s rapidly evolving oncology landscape, life science companies need more than data—they need actionable evidence. With deep expertise in real-world evidence, Aptitude Health delivers tailored registries and observational research programs to help answer your most critical strategic and scientific questions.​

With Registry Solutions, partner with us to​
✅ Fill evidence gaps​
✅ Capture longitudinal patient journeys​
✅ Generate high-quality data aligned to your goals​
✅ Move faster and more flexibly than traditional models​

Explore our registry and observational research services: https://www.aptitudehealth.com/registry-services/

05/19/2026

When frontline immunotherapy stops working, what comes next? In our latest Aptitude Health interview, melanoma expert Dr Omid Hamid and patient advocate Sam Guild (AIM at Melanoma) share critical insights on navigating treatment challenges, clinical trial access, and emerging therapies.​

Watch and read the full discussion to learn how clinicians, advocates, and patients are working together to push melanoma care forward: https://www.aptitudehealth.com/oncology-news/addressing-treatment-challenges-after-anti-pd-1-failure-in-advanced-melanoma/

05/14/2026

In oncology, data alone is not enough. What matters is how the data is understood—and why decisions are made. ​

Aptitude Health helps life science teams move beyond surface-level data to uncover the real drivers of hematology and oncology decision-making. We bring these insights to life—connecting you to the perspectives that shape clinical practice and patient outcomes.​

At the center is our Axess Network: a global community of 6,500+ oncology and hematology experts delivering unbiased perspectives and real-world evidence you can act on with confidence.​

Find out more: https://www.aptitudehealth.com/contact-us/

05/12/2026

The health care industry is drowning in data—yet starving for real insights. Hear from our CEO, Jez Moulding, on how Aptitude Health helps life science companies turn scientific and clinical knowledge into real‑world oncology insight, powered by our global Axess Network of 6,500+ oncologists. ​

Meet us at ASCO | Booth 12119

Learn more about us: https://www.aptitudehealth.com/contact-us/

05/07/2026

Our upcoming Global Leukemia Academy program will feature 2 region-specific interactive sessions for Asia-Pacific and Latin America, focused on advancing care in acute lymphoblastic leukemia (ALL).​

Led by faculty chair Elias Jabbour, MD, of MD Anderson Cancer Center, USA, each session will address regional and clinical practice considerations while examining shared global advances in ALL.​

📆 June 18, 2026 · Virtual Program​

🕗 Asia-Pacific Region: 8.00 AM – 9.00 AM (Shanghai) –​
https://globalleukemiaacademy.com/treating-acute-leukemias-in-the-asia-pacific-region-june-2026/ ​

🕖 Latin America: 7.00 PM – 8.00 PM (Brazil) – https://globalleukemiaacademy.com/treating-acute-leukemias-in-the-latin-america-region-june-2026/

Session topics include​
· Global progress in ALL ​
· Key data highlights from 2026 conferences​
· Case-based discussion incorporating genomic testing​
· Opportunities and challenges across everyday regional practice settings